Literature DB >> 1359898

Neurobiology of motivation: double dissociation of two motivational mechanisms mediating opiate reward in drug-naive versus drug-dependent animals.

A Bechara1, F Harrington, K Nader, D van der Kooy.   

Abstract

Separate brain manipulations double dissociate two motivational mechanisms underlying the rewarding effects of opiates. Lesions of the brain stem tegmental pedunculopontine nucleus block the rewarding properties of morphine in drug-naive, but not in drug-dependent, rats. Neuroleptics (which block the action of the neurotransmitter dopamine) abolished opiate motivational effects in drug-dependent, but not in drug-naive, rats in place conditioning paradigms. This second dopaminergic opiate reward mechanism mediates morphine's alleviation of the withdrawal distress associated with abstinence in opiate-dependent animals. Furthermore, neuroleptic-induced blockade of food-related motivational effects in food-deprived, but not in food-sated (non-food-deprived), animals suggests that the neural substrates of motivational events do not dissociate along the line between different rewarding stimuli but along the line between deprivation and nondeprivation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1359898     DOI: 10.1037//0735-7044.106.5.798

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  19 in total

1.  Blockade of muscarinic acetylcholine receptors in the ventral tegmental area prevents acquisition of food-rewarded operant responding in rats.

Authors:  Ruth Sharf; Jennifer McKelvey; Robert Ranaldi
Journal:  Psychopharmacology (Berl)       Date:  2006-03-09       Impact factor: 4.530

Review 2.  New insights into the specificity and plasticity of reward and aversion encoding in the mesolimbic system.

Authors:  Susan F Volman; Stephan Lammel; Elyssa B Margolis; Yunbok Kim; Jocelyn M Richard; Mitchell F Roitman; Mary Kay Lobo
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

Review 3.  Opioid-induced rewards, locomotion, and dopamine activation: A proposed model for control by mesopontine and rostromedial tegmental neurons.

Authors:  Stephan Steidl; David I Wasserman; Charles D Blaha; John S Yeomans
Journal:  Neurosci Biobehav Rev       Date:  2017-09-23       Impact factor: 8.989

4.  Lateral hypothalamic orexin/hypocretin neurons that project to ventral tegmental area are differentially activated with morphine preference.

Authors:  Kimberlei A Richardson; Gary Aston-Jones
Journal:  J Neurosci       Date:  2012-03-14       Impact factor: 6.167

Review 5.  Understanding opioid reward.

Authors:  Howard L Fields; Elyssa B Margolis
Journal:  Trends Neurosci       Date:  2015-01-29       Impact factor: 13.837

6.  High fat diet intake during pre and periadolescence impairs learning of a conditioned place preference in adulthood.

Authors:  Gregory J Privitera; Arturo R Zavala; Federico Sanabria; Kristin L Sotak
Journal:  Behav Brain Funct       Date:  2011-06-26       Impact factor: 3.759

7.  Dorsal as well as ventral striatal lesions affect levels of intravenous cocaine and morphine self-administration in rats.

Authors:  Nobuyoshi Suto; Roy A Wise; Paul Vezina
Journal:  Neurosci Lett       Date:  2011-02-12       Impact factor: 3.046

8.  Deprivation state switches the neurobiological substrates mediating opiate reward in the ventral tegmental area.

Authors:  K Nader; D van der Kooy
Journal:  J Neurosci       Date:  1997-01-01       Impact factor: 6.167

9.  Dopamine D1 receptors are not critical for opiate reward but can mediate opiate memory retrieval in a state-dependent manner.

Authors:  Ryan Ting-A-Kee; Laura E Mercuriano; Hector Vargas-Perez; Susan R George; Derek van der Kooy
Journal:  Behav Brain Res       Date:  2013-03-26       Impact factor: 3.332

Review 10.  An update on the connections of the ventral mesencephalic dopaminergic complex.

Authors:  L Yetnikoff; H N Lavezzi; R A Reichard; D S Zahm
Journal:  Neuroscience       Date:  2014-04-13       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.